MGP Ingredients, Inc. v. Mars, Inc.

465 F. Supp. 2d 1109, 2006 U.S. Dist. LEXIS 88802, 2006 WL 3530726
CourtDistrict Court, D. Kansas
DecidedDecember 7, 2006
Docket06-2318-JWL
StatusPublished
Cited by7 cases

This text of 465 F. Supp. 2d 1109 (MGP Ingredients, Inc. v. Mars, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Kansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
MGP Ingredients, Inc. v. Mars, Inc., 465 F. Supp. 2d 1109, 2006 U.S. Dist. LEXIS 88802, 2006 WL 3530726 (D. Kan. 2006).

Opinion

MEMORANDUM AND ORDER

LUNGSTRUM, District Judge.

This lawsuit involves the popular Gree-nies® chew for dogs, which has been sold for years by defendant S & M NuTec LLC (SMN) using, until recently, a formulation containing confidential ingredients supplied by plaintiff MGP Ingredients (MGPI). In April of 2006, defendant Mars, Incorporated (Mars) acquired SMN. Plaintiffs complaint generally alleges that Mars destroyed the relationship between SMN and MGPI by treating the agreements between them as unenforceable and by marketing an improved Greenies® dog chew using a purportedly “totally new” Mars formulation. MGPI alleges that, in doing so, Mars infringed on MGPI’s Gree-nies® formulation patent and misappropriated MGPI’s trade secrets. This matter is before the court on Defendants’ Partial Motion to Dismiss (doc. # 15). Therein, defendants ask the court to dismiss MGPI’s claims for tortious interference and misappropriation of trade secrets for failure to state a claim upon which relief can be granted. For the reasons explained below, defendants’ motion is denied.

BACKGROUND 1

Plaintiffs complaint alleges that for a *1111 number of years MGPI has been making ingredients for foods, pet foods, and various other compositions, typically using protein polymers as a base for more complex custom formulations. The exact compositions of these formulations are closely guarded trade secrets of MGPI. SMN was formerly one of MGPI’s customers. SMN marketed a popular dog chew named Gree-nies®. MGPI made the formulation for these products (the “Greenies® formulation”) for SMN on an as-needed basis under a confidentiality agreement. The Greenies® formulation includes ingredients covered by an MGPI patent.

In October of 2005, MGPI and SMN entered into a long-term Supply Agreement which essentially provided that SMN would buy all of its needs for the Gree-nies® formulation from MGPI and that, in turn, MGPI would not sell the Greenies® formulation to anyone else unless SMN’s purchases of the Greenies® formulation fell below certain predefined limits. At the same time, MGPI and SMN entered into a Confidentiality Agreement which provided that SMN would use MGPI’s confidential information solely for doing business with MGPI. They also entered into a Confidentiality Technology Development Agreement which provided for a joint research effort by MGPI and SMN for the purpose of developing an improved Gree-nies® formulation. The Supply Agreement applied to the Greenies® formulation, the improved Greenies® formulation, and to any improvements on either, whether made under MGPI’s patent and whether made by MGPI or SMN.

Approximately seven months later, Mars acquired one hundred percent of the stock of SMN in order to give Mars a significant position in the market for dog chew products like Greenies®. Shortly after this acquisition, SMN and MGPI met to discuss and reveal their work to make an improved Greenies® formulation. SMN allowed Mars to have access to the Gree-nies® formulation improvements. After Mars received confidential information over a period of weeks, it announced to MGPI that it had discovered its own, new formulation for Greenies® (the “Mars formulation”). Mars then began claiming, falsely, that it had invented a “totally new” formulation. Mars represented to MGPI, for example, that a particular component was missing from the Mars formulation when, in fact, according to MGPI, “the opposite was true.” (Compl.(doc.# 1), ¶ 18, at 5.) Mars also provided MGPI with a list of the components in the Mars formulation, but it would not disclose how much of each component was present. Mars’ purpose in claiming that it had a “totally new” formulation was to repudiate the commercial relationship between MGPI and SMN. Mars took the position that neither the Supply Agreement nor the Confidential Technology Development Agreement applied to a situation in which the formulation was a “totally new” Mars-invented formulation. Mars told MGPI that the Supply Agreement did not apply to the Mars formulation and that Mars would provide MGPI the full complement of raw materials for the Mars formulation and only permit MGPI to process those materials into the Mars formulation on a toll basis. Ultimately, SMN ceased purchasing formulations of any kind from MGPI.

In fact, the Mars formulation is based in part on secret ingredients in the Gree-nies® formulation. The Mars formulation takes advantage of technical advances de *1112 veloped by MGPI and SMN for the improved Greenies® formulation.

Based on these allegations, MGPI asserts claims against SMN and Mars for patent infringement, tortious interference, misappropriation of trade secrets, and breach of contract, and seeks a preliminary and permanent injunction. Defendants now ask the court to dismiss plaintiffs claims for tortious interference (Count II) and misappropriation of trade secrets (Count III) for failure to state a claim upon which relief can be granted. Defendants contend that the tortious interference claim should be dismissed because MGPI has failed to plead that Mars’ procurement of SMN’s breach was intentional and, additionally, the absence of justification in that a parent corporation cannot tortiously interfere with its subsidiary’s contract as a matter of law. Defendants also contend that the misappropriation of trade secrets claim should be dismissed because plaintiffs complaint does not allege that defendants misappropriated anything that would qualify as a valid trade secret.

LEGAL STANDARD FOR A MOTION TO DISMISS

Dismissal for failure to state a claim upon which relief can be granted under Fed.R.Civ.P. 12(b)(6) is appropriate only when “it appears beyond a doubt that the plaintiff can prove no set of facts in support of [its] claims which would entitle [it] to relief,” Beedle v. Wilson, 422 F.3d 1059, 1063 (10th Cir.2005) (quoting Conley v. Gibson, 355 U.S. 41, 45-46, 78 S.Ct. 99, 2 L.Ed.2d 80 (1957)), or when an issue of law is dispositive, Neitzke v. Williams, 490 U.S. 319, 326, 109 S.Ct. 1827, 104 L.Ed.2d 338 (1989). The court accepts as true all well-pleaded facts, as distinguished from conclusory allegations, and all reasonable inferences from those facts are viewed in favor of the plaintiff. Beedle, 422 F.3d at 1063. The issue in resolving such a motion is “not whether [the] plaintiff will ultimately prevail, but whether the claimant is entitled to offer evidence to support the claims.” Swierkiewicz v. Sorema N.A., 534 U.S. 506, 511, 122 S.Ct. 992, 152 L.Ed.2d 1 (2002) (quotation omitted); accord Beedle, 422 F.3d at 1063.

ANALYSIS

For the reasons explained below, the court finds that MGPI’s complaint adequately alleges that Mars’ interference with the contract was intentional.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
465 F. Supp. 2d 1109, 2006 U.S. Dist. LEXIS 88802, 2006 WL 3530726, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mgp-ingredients-inc-v-mars-inc-ksd-2006.